Selected Tag: Granules
Selected Tag: Granules

Granules India Subsidiary Gets US FDA Tentative Nod For ADHD Generic Drug

BasisPoint Insight

December 22, 2025 at 6:04 AM IST

Market Wrap

Indices Recover Modestly, Brace for RBI Decision and Rupee Volatility

An end-of-day recap of all that transpired in the Indian markets, highlighting the major price movements and the factors driving them

Dehuti Jani

December 4, 2025 at 11:43 AM IST

Article related image

Most Indian Pharma Exports May Escape US Tariff, But Uncertainty Clouds Branded Generics 

US 100% tariff plan sparks confusion: if branded generics are treated as patented drugs, India is safe; if as branded imports, then some pharma exports face trouble.

Ajay Srivastava

September 26, 2025 at 7:56 AM IST

Article related image

Istock.com/moussa81

Granules India's Joint MD & CEO Kandiraju Rao Resigns, Effective July 31

BasisPoint Insight

July 21, 2025 at 9:24 AM IST

Granules India Extends ₹2.7 Billion Guarantee For Swiss Unit’s MUFG Bank Loan

BasisPoint Insight

July 11, 2025 at 7:16 AM IST

Granules India's US Unit Gets One FDA Observation, Says Issue Resolved

BasisPoint Insight

June 30, 2025 at 9:56 AM IST

Granules India Gets One USFDA Observation For Hyderabad API Plant

BasisPoint Insight

June 23, 2025 at 10:26 AM IST

Granules India January-March Profit Up 17% On Year; 2024-25 Earnings Rise 24%

BasisPoint Insight

May 30, 2025 at 8:14 AM IST

Granules India Completes Acquisition Of Swiss Peptide Maker Senn Chemicals

BasisPoint Insight

April 11, 2025 at 3:53 PM IST

The Bureau

Is India Starving for Nutrition? The Protein Crisis in a Calorie-Sufficient Nation
Learning to Shoot: I Tried to Fly Before I Could Walk
Image